11
64 Cu-DOTA-alendronate PET Imaging in Localizing and Characterizing Breast Calcifications in Participants Before Undergoing Mastectomy
Condition(s):Breast Carcinoma; CalcificationLast Updated:February 17, 2022Recruiting
Alendronate Sodium: 206 Clinical Trials, Page 2 of 21
Hide Studies Not Open or Pending
12
Alendronate in an Weekly Effervescent Tablet Formulation Following Denosumab Discontinuation
Condition(s):Postmenopausal OsteoporosisLast Updated:March 16, 2022Recruiting
13
Pilot Study of Bisphosphonates for Breast Cancer
Condition(s):Breast NeoplasmsLast Updated:October 22, 2020Terminated
14
Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis Patients
Condition(s):Cystic Fibrosis; Osteoporosis; Bone Diseases, MetabolicLast Updated:October 23, 2008Completed
15
Fasting Study of Alendronate Sodium Tablets (70 mg) and Fosamax Tablets (70 mg)
Condition(s):HealthyLast Updated:November 13, 2009Completed
16
Fasting Study of Alendronate Sodium Tablets (10 mg) and Fosamax Tablets (10 mg)
Condition(s):HealthyLast Updated:September 24, 2009Completed
17
Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis
Condition(s):OsteoporosisLast Updated:January 19, 2011Completed
18
Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis
Condition(s):OsteoporosisLast Updated:November 7, 2010Completed
19
The Change of Bone Markers After Low Dose Alendronate in Postmenopausal Women With Bone Loss
Condition(s):OsteoporosisLast Updated:August 5, 2014Completed
20
Efficacy and Safety of Brand Versus Generic Alendronate for Osteoporosis Treatment
Condition(s):OsteoporosisLast Updated:September 29, 2021Completed